Animal models and the prediction of efficacy in clinical trials of analgesic drugs: A critical appraisal and call for uniform reporting standards

a Pain Research, Department of Anaesthetics, Pain Medicine and Intensive Care, Faculty of Medicine, Imperial College London, Chelsea & Westminster Hospital Campus, 369 Fulham Road, London SW10 9NH, UK b Mari Lowe Centre for Comparative Oncology Research, School of Veterinary Medicine, University of Pennsylvania, 3900 Delancey Street, Philadelphia, PA 19104-6010, USA c Department of Anesthesia, Wake Forest University School of Medicine, Medical Center Boulevard, Winston Salem, NC 27157, USA d Department of Anaesthesiology and Intensive Care Medicine, Helsinki University Central Hospital, Helsinki, Finland e Pfizer Global Research and Development, Sandwich CT13 9NJ, UK f Department of Psychology, McGill University, 1205 Dr. Penfield Avenue, Montreal, Que., Canada H3A 1B1 g Bitop AG, Stockumerstr. 28, 58453 Witten, Germany

[1]  Robert W. Johnson,et al.  A study of shingles and the development of postherpetic neuralgia in East London , 2003, Journal of medical virology.

[2]  A. Rice,et al.  Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study , 2001, PAIN.

[3]  V. Kontinen,et al.  Predictive validity of neuropathic pain models in pharmacological studies with a behavioral outcome in the rat: A systematic review , 2003 .

[4]  J. Mogil,et al.  The case for the inclusion of female subjects in basic science studies of pain , 2005, Pain.

[5]  J. Coyne,et al.  A novel approach to the use of animals in studies of pain: validation of the canine brief pain inventory in canine bone cancer. , 2009, Pain medicine.

[6]  J. Mogil,et al.  What should we be measuring in behavioral studies of chronic pain in animals? , 2004, Pain.

[7]  M. Malcangio,et al.  A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats , 1998, Pain.

[8]  J. Breuer,et al.  Further characterization of a rat model of varicella zoster virus–associated pain: Relationship between mechanical hypersensitivity and anxiety-related behavior, and the influence of analgesic drugs , 2007, Neuroscience.

[9]  G. Bennett,et al.  Ethosuximide reverses paclitaxel- and vincristine-induced painful peripheral neuropathy , 2004, Pain.

[10]  D. Moher,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Journal of the American Podiatric Medical Association.

[11]  C. Cain,et al.  Analgesic effects of adrenal chromaffin allografts: contingent on special procedures or due to experimenter bias? , 2003, The journal of pain : official journal of the American Pain Society.

[12]  Kennon Heard,et al.  Emergency medicine animal research: does use of randomization and blinding affect the results? , 2003, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[13]  G. Bove,et al.  Mechanical sensory threshold testing using nylon monofilaments: The pain field’s “Tin Standard” , 2006, Pain.

[14]  A. Rice,et al.  Comparison of psychological and physical function in neuropathic pain and nociceptive pain: Implications for cognitive behavioral pain management programs , 2008, European journal of pain.

[15]  Glenn W. Stevenson,et al.  Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6J mice. , 2006, The journal of pain : official journal of the American Pain Society.

[16]  P. Fuchs,et al.  A Behavioral Test Paradigm to Measure the Aversive Quality of Inflammatory and Neuropathic Pain in Rats , 2000, Experimental Neurology.

[17]  Douglas G. Altman,et al.  The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials , 2001, The Lancet.

[18]  L. Leventhal,et al.  Predictive validity of animal pain models? A comparison of the pharmacokinetic–pharmacodynamic relationship for pain drugs in rats and humans , 2008, Neuropharmacology.

[19]  Andrew R Segerdahl,et al.  Characterization of rodent models of HIV-gp120 and anti-retroviral-associated neuropathic pain. , 2007, Brain : a journal of neurology.

[20]  J. Eisenach,et al.  Did experimenter bias conceal the efficacy of spinal opioids in previous studies with the spinal nerve ligation model of neuropathic pain? , 2004, Anesthesiology.

[21]  H. Anderson,et al.  Varicella zoster virus induces neuropathic changes in rat dorsal root ganglia and behavioral reflex sensitisation that is attenuated by gabapentin or sodium channel blocking drugs , 2005, Pain.

[22]  Rolf-Detlef Treede,et al.  Anxiety-like behaviour in rats with mononeuropathy is reduced by the analgesic drugs morphine and gabapentin , 2008, PAIN.

[23]  Julia H. Littell,et al.  Systematic Reviews and Meta-Analysis , 2008 .

[24]  G. Blackburn-Munro,et al.  Pharmacological characterisation of place escape/avoidance behaviour in the rat chronic constriction injury model of neuropathic pain , 2006, Psychopharmacology.

[25]  L. Mignini,et al.  Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research , 2006, BMC medical research methodology.

[26]  Andrew S.C. Rice,et al.  Pharmacological, behavioural and mechanistic analysis of HIV-1 gp120 induced painful neuropathy , 2007, PAIN®.

[27]  F. Birklein,et al.  Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values , 2006, PAIN.

[28]  L. Urbán,et al.  Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat , 1999, Pain.

[29]  T. Gordh,et al.  Peripheral neuropathic pain—a multidimensional burden for patients , 2001, European journal of pain.

[30]  J. Levine,et al.  Novel mechanism of enhanced nociception in a model of AIDS therapy-induced painful peripheral neuropathy in the rat , 2004, Pain.

[31]  P. Sandercock,et al.  Comparison of treatment effects between animal experiments and clinical trials: systematic review , 2006, BMJ : British Medical Journal.

[32]  D. Hackam,et al.  Translating animal research into clinical benefit , 2007, BMJ : British Medical Journal.

[33]  R. Bandler,et al.  A subpopulation of rats show social and sleep–waking changes typical of chronic neuropathic pain following peripheral nerve injury , 2003, The European journal of neuroscience.

[34]  Malcolm Macleod,et al.  How can we improve the pre-clinical development of drugs for stroke? , 2007, Trends in Neurosciences.

[35]  Jim Schnabel,et al.  Neuroscience: Standard model , 2008, Nature.

[36]  J. Farrar,et al.  Core outcome measures for chronic pain clinical trials: IMMPACT recommendations , 2003, Pain.

[37]  N. B. Finnerupa,et al.  Algorithm for neuropathic pain treatment: An evidence based proposal , 2005 .

[38]  J. Quinn,et al.  Behavioural changes in the rat following infection with varicella-zoster virus. , 1999, The Journal of general virology.

[39]  Elissa J Chesler,et al.  Identification and ranking of genetic and laboratory environment factors influencing a behavioral trait, thermal nociception, via computational analysis of a large data archive , 2002, Neuroscience & Biobehavioral Reviews.

[40]  Daniel J. Levitin,et al.  Social Modulation of Pain as Evidence for Empathy in Mice , 2006, Science.